A Glutamate Transporter GLT1, in the Treatment of Bipolarity
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In Bethesda
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has public registry information. It focuses on bipolarity and currently lists study information in the United States.
In BethesdaThis study is completed. It focuses on anxiety and currently lists study information in China.
In BeijingThis study has public registry information. It focuses on depression and currently lists study information in Switzerland.
In NottwilThis study is completed. It focuses on PTSD and currently lists study information in the United States.
Multiple locations, including ClevelandThis study is completed in China. It focuses on ADHD.
Multiple locations, including BeijingThis study is completed. It focuses on ADHD and currently lists study information in Austria, Belgium, Finland, France, Germany, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland, and the United Kingdom.
Multiple locations, including ViennaThis study is active but not recruiting. It focuses on schizophrenia and currently lists study information in Japan.
In Kure-shiThis study is completed. It focuses on schizophrenia and currently lists study information in Japan.
In Aizu-WakamatsuThis study is completed. It focuses on schizophrenia and currently lists study information in Japan.
In KurayoshiThis study is completed. It focuses on bipolarity and currently lists study information in Japan, Lithuania, Malaysia, the Philippines, Russian Federation, Slovakia, Taiwan, and Ukraine.
Multiple locations, including TokyoThis study is completed. It focuses on ADHD and currently lists study information in Japan.
Multiple locations, including ChibaThis study is completed. It focuses on ADHD and currently lists study information in Taiwan.
In TaipeiHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.